Inspire Investing’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-18,911
Closed -$405K – 1283
2026
Q1
$405K Buy
+18,911
New +$266K 0.02% 855

Other funds holding DAWN

Inspire Investing's DAWN Position: Q2 2026 in Review

Inspire Investing sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 18,911 shares — an estimated $405K sold.

Inspire Investing first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $405K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Inspire Investing reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Inspire Investing sold 18,911 Day One Biopharmaceuticals shares in Q2 2026, an estimated $405K.
  • Inspire Investing first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Inspire Investing's Day One Biopharmaceuticals position peaked at $405K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.